BAFNA PHARMACEUTICALS
Back to All Ratios
|
BAFNA PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 19.62 | 14.69 | 11.73 | 28.05 | 31.52 |
What is the latest Price to Cash Earnings (PCE) ratio of BAFNA PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 19.62 |
| Mar2024 | 14.69 |
| Mar2023 | 11.73 |
| Mar2022 | 28.05 |
| Mar2021 | 31.52 |
How is Price to Cash Earnings (PCE) of BAFNA PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 19.62 | 33.56 | |
| Mar2024 | 14.69 | 25.23 | |
| Mar2023 | 11.73 | -58.18 | |
| Mar2022 | 28.05 | -11.01 | |
| Mar2021 | 31.52 | - | |
Other Financial Ratios of BAFNA PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹407.6 Cr | 16.2% | 2.7% | 97.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 16.2% |
2.7% |
97.5% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses